PMFA
GMAB icon

Plante Moran Financial Advisors’s Genmab GMAB Stock Holding History

Plante Moran Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-151
Closed -$5K – 931
2022
Q2 		$5K Buy
+151
New +$4.89K ﹤0.01% 711
2021
Q3 		– Sell
-100
Closed -$4K – 958
2021
Q2 		$4K Hold
100
– – ﹤0.01% 817
2021
Q1 		$3K Hold
100
– – ﹤0.01% 860
2020
Q4 		$4K Buy
+100
New +$3.74K ﹤0.01% 716

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Plante Moran Financial Advisors's GMAB Position: Q3 2022 in Review

Plante Moran Financial Advisors sold out of Genmab (GMAB) in Q3 2022, closing a stake of 151 shares — an estimated $5K sold.

Plante Moran Financial Advisors first reported a position in GMAB in Q4 2020 and held it in 4 quarters. The position peaked at $5K in Q2 2022. 193 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Plante Moran Financial Advisors reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 151 Genmab shares in Q3 2022, an estimated $5K.
  • Plante Moran Financial Advisors first reported a position in Genmab in Q4 2020 and held it in 4 quarters.
  • Plante Moran Financial Advisors's Genmab position peaked at $5K in Q2 2022.
  • 193 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2022, filed 2 Nov 2022.